These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 31246117

  • 1. Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.
    Wachholtz A, Gonzalez G, Ziedonis D.
    Am J Drug Alcohol Abuse; 2019; 45(5):495-505. PubMed ID: 31246117
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR, Darnall BD, You DS.
    JMIR Res Protoc; 2024 Jun 06; 13():e53784. PubMed ID: 38843513
    [Abstract] [Full Text] [Related]

  • 3. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A, Gonzalez G.
    Drug Alcohol Depend; 2014 Dec 01; 145():143-9. PubMed ID: 25456326
    [Abstract] [Full Text] [Related]

  • 4. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B, Nguyen T, Harris S, Madeira J, Totaram R, Randall-Kosich O, Atkins D, Ford J.
    Am J Drug Alcohol Abuse; 2020 Sep 02; 46(5):589-603. PubMed ID: 32543922
    [Abstract] [Full Text] [Related]

  • 5. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR.
    Pain Physician; 2021 Mar 02; 24(2):E249-E256. PubMed ID: 33740362
    [Abstract] [Full Text] [Related]

  • 6. Distress Tolerance in the Comorbid Chronic Pain and Opioid Use Disorder Population.
    Wilson SC, Shaffer JA, Wachholtz AB.
    J Addict Med; 2021 Mar 02; 17(3):e164-e171. PubMed ID: 37267174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K, Jia P, Bhargava S, Zhang Y, Reza T, Peng YB, Wang GG.
    Scand J Pain; 2017 Oct 02; 17():167-173. PubMed ID: 28988103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship between sleep and opioids in chronic pain patients.
    Frers A, Shaffer J, Edinger J, Wachholtz A.
    J Behav Med; 2021 Jun 02; 44(3):412-420. PubMed ID: 33609232
    [Abstract] [Full Text] [Related]

  • 12. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B, Atkins D.
    Am J Drug Alcohol Abuse; 2020 Nov 01; 46(6):749-760. PubMed ID: 32969757
    [Abstract] [Full Text] [Related]

  • 13. Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff.
    Andraka-Christou B, Atkins D, Madeira J, Silverman RD.
    Drug Alcohol Rev; 2020 Jul 01; 39(5):583-587. PubMed ID: 32394525
    [Abstract] [Full Text] [Related]

  • 14. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
    Randall-Kosich O, Andraka-Christou B, Totaram R, Alamo J, Nadig M.
    J Addict Med; 2020 Jul 01; 14(4):e44-e52. PubMed ID: 31651562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder.
    Maricich YA, Xiong X, Gerwien R, Kuo A, Velez F, Imbert B, Boyer K, Luderer HF, Braun S, Williams K.
    Curr Med Res Opin; 2021 Feb 01; 37(2):175-183. PubMed ID: 33140981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.